The Legal Intelligencer | News
By Robert Storace | May 13, 2019
Connecticut is leading a 44-state coalition, alleging price-fixing by 20 makers of generic drugs. Their lawsuit seeks payments of billions of dollars to these states.
The Legal Intelligencer | News
By Max Mitchell | May 3, 2019
Judge Harvey Bartle III said that the complaints were "full of boilerplate language unrelated to the individual case," and were "the antitheses of how a proper federal complaint should be drafted."
The Legal Intelligencer | Commentary
By Steve Schain | May 2, 2019
With the FDA "locked and loaded," and billions of annual sales and "deal flow capital" hanging in the balance, the cannabis and hemp industries are questioning whether their products can be manufactured, sold and marketed without vending adulterated or misbranded food, drugs and cosmetics, or making false or unsubstantiated health claims.
The Legal Intelligencer | News
By Max Mitchell | April 25, 2019
The verdict came after a three-week trial in Judge Kenneth Powell's courtroom, and the award included $20 million in compensatory damages, as well as $100 million in punitive damages.
The Legal Intelligencer | News
By Tom McParland | April 19, 2019
An investor in AmerisourceBergen Corp. is taking aim at the directors of the Chesterbrook-based drug wholesaler with a books-and-records suit in Delaware seeking to investigate potential wrongdoing associated with the opioid crisis.
The Legal Intelligencer | News
By Max Mitchell | April 12, 2019
A unanimous three-judge Superior Court panel on Thursday affirmed the multimillion-dollar verdict in Carlino v. Ethicon, which a jury awarded in February 2016.
The Legal Intelligencer | News
By P.J. D'Annunzio | April 11, 2019
After reviewing motions to dismiss an antitrust lawsuit against pharmaceutical CEO-turned-convicted-felon Martin Shkreli and others, a federal judge in Pennsylvania has ordered additional discovery regarding defense claims that the plaintiff is a "made-for-litigation shell company" formed by a former Winston & Strawn associate.
The Legal Intelligencer | Commentary
By Christopher Ezold | April 11, 2019
A question that investors frequently ask of emerging growth life sciences companies is whether they have considered how to monetize the data they will inevitably collect in the development, marketing and sale of their service or product.
By Max Mitchell | April 4, 2019
Nationwide litigation over claims that Bayer and Johnson & Johnson failed to warn about the risks of the blood thinner Xarelto has come to a global settlement of $775 million.
The Legal Intelligencer | News
By Max Mitchell | April 4, 2019
A three-judge Superior Court panel determined that ties between Ethicon, a J&J subsidiary that is the main defendant in the pelvic mesh litigation in Philadelphia, and Secant, a Pennsylvania-based company that was involved in manufacturing the mesh product at issue, were sufficient to establish jurisdiction in the Keystone State.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS